Healthcare & Life Sciences
ImmuneBridge
United Statesimmunebridge.com
ImmuneBridge is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
activeseries-a
series-a
Stage
2
Investors
About ImmuneBridge
ImmuneBridge is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
ImmuneBridge develops allogeneic cellular immunotherapies using a proprietary stem cell expansion technology to create scalable, high-quality immune cell therapies for cancer and other diseases.
Explore ImmuneBridge's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.